img

Global Rituximab Injection Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Rituximab Injection Market Insights, Forecast to 2034

Rituximab injection sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer.
Global Rituximab Injection market is expected to reach to US$ 1940 million in 2024, with a positive growth of %, compared with US$ 1502 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Rituximab Injection industry is evaluated to reach US$ 5851 million in 2029. The CAGR will be 20.2% during 2024 to 2029.
Globally, Rituximab Injection key manufacturers include Pfizer, Amgen, Roche, Celltrion, Innovent Biologics, Intas Pharmaceuticals, Shanghai Henlius Biotech, Fosun-Pharmaceutical and Lexicare Pharma, etc. Pfizer, Amgen, Roche are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Rituximab Injection were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Rituximab Injection market and estimated to attract more attentions from industry insiders and investors.
Rituximab Injection can be divided into 100 ml and 500 ml, etc. 100 ml is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Rituximab Injection is widely used in various fields, such as Hospitals, Clinics and Others,, etc. Hospitals provides greatest supports to the Rituximab Injection industry development. In 2022, global % sales of Rituximab Injection went into Hospitals filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Rituximab Injection market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Rituximab Injection market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
Amgen
Roche
Celltrion
Innovent Biologics
Intas Pharmaceuticals
Shanghai Henlius Biotech
Fosun-Pharmaceutical
Lexicare Pharma
Healthiza Lifescience
Kavya Pharma
Cadila Pharmaceuticals
Dr Reddy’s Laboratories
Hetero Group
Probiomed
TRPharma
Zenotech Laboratories
Segment by Type
100 ml
500 ml

Segment by Application


Hospitals
Clinics
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Rituximab Injection plant distribution, commercial date of Rituximab Injection, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Rituximab Injection introduction, etc. Rituximab Injection Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Rituximab Injection
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Rituximab Injection Product Introduction
1.2 Market by Type
1.2.1 Global Rituximab Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 100 ml
1.2.3 500 ml
1.3 Market by Application
1.3.1 Global Rituximab Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Rituximab Injection Sales Estimates and Forecasts 2018-2029
2.2 Global Rituximab Injection Revenue by Region
2.2.1 Global Rituximab Injection Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Rituximab Injection Revenue by Region (2018-2024)
2.2.3 Global Rituximab Injection Revenue by Region (2024-2029)
2.2.4 Global Rituximab Injection Revenue Market Share by Region (2018-2029)
2.3 Global Rituximab Injection Sales Estimates and Forecasts 2018-2029
2.4 Global Rituximab Injection Sales by Region
2.4.1 Global Rituximab Injection Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Rituximab Injection Sales by Region (2018-2024)
2.4.3 Global Rituximab Injection Sales by Region (2024-2029)
2.4.4 Global Rituximab Injection Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Rituximab Injection Sales by Manufacturers
3.1.1 Global Rituximab Injection Sales by Manufacturers (2018-2024)
3.1.2 Global Rituximab Injection Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Rituximab Injection in 2022
3.2 Global Rituximab Injection Revenue by Manufacturers
3.2.1 Global Rituximab Injection Revenue by Manufacturers (2018-2024)
3.2.2 Global Rituximab Injection Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Rituximab Injection Revenue in 2022
3.3 Global Key Players of Rituximab Injection, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Rituximab Injection Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Rituximab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Rituximab Injection, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Rituximab Injection, Product Offered and Application
3.8 Global Key Manufacturers of Rituximab Injection, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Rituximab Injection Sales by Type
4.1.1 Global Rituximab Injection Historical Sales by Type (2018-2024)
4.1.2 Global Rituximab Injection Forecasted Sales by Type (2024-2029)
4.1.3 Global Rituximab Injection Sales Market Share by Type (2018-2029)
4.2 Global Rituximab Injection Revenue by Type
4.2.1 Global Rituximab Injection Historical Revenue by Type (2018-2024)
4.2.2 Global Rituximab Injection Forecasted Revenue by Type (2024-2029)
4.2.3 Global Rituximab Injection Revenue Market Share by Type (2018-2029)
4.3 Global Rituximab Injection Price by Type
4.3.1 Global Rituximab Injection Price by Type (2018-2024)
4.3.2 Global Rituximab Injection Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Rituximab Injection Sales by Application
5.1.1 Global Rituximab Injection Historical Sales by Application (2018-2024)
5.1.2 Global Rituximab Injection Forecasted Sales by Application (2024-2029)
5.1.3 Global Rituximab Injection Sales Market Share by Application (2018-2029)
5.2 Global Rituximab Injection Revenue by Application
5.2.1 Global Rituximab Injection Historical Revenue by Application (2018-2024)
5.2.2 Global Rituximab Injection Forecasted Revenue by Application (2024-2029)
5.2.3 Global Rituximab Injection Revenue Market Share by Application (2018-2029)
5.3 Global Rituximab Injection Price by Application
5.3.1 Global Rituximab Injection Price by Application (2018-2024)
5.3.2 Global Rituximab Injection Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Rituximab Injection Market Size by Type
6.1.1 US & Canada Rituximab Injection Sales by Type (2018-2029)
6.1.2 US & Canada Rituximab Injection Revenue by Type (2018-2029)
6.2 US & Canada Rituximab Injection Market Size by Application
6.2.1 US & Canada Rituximab Injection Sales by Application (2018-2029)
6.2.2 US & Canada Rituximab Injection Revenue by Application (2018-2029)
6.3 US & Canada Rituximab Injection Market Size by Country
6.3.1 US & Canada Rituximab Injection Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Rituximab Injection Sales by Country (2018-2029)
6.3.3 US & Canada Rituximab Injection Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Rituximab Injection Market Size by Type
7.1.1 Europe Rituximab Injection Sales by Type (2018-2029)
7.1.2 Europe Rituximab Injection Revenue by Type (2018-2029)
7.2 Europe Rituximab Injection Market Size by Application
7.2.1 Europe Rituximab Injection Sales by Application (2018-2029)
7.2.2 Europe Rituximab Injection Revenue by Application (2018-2029)
7.3 Europe Rituximab Injection Market Size by Country
7.3.1 Europe Rituximab Injection Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Rituximab Injection Sales by Country (2018-2029)
7.3.3 Europe Rituximab Injection Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Rituximab Injection Market Size
8.1.1 China Rituximab Injection Sales (2018-2029)
8.1.2 China Rituximab Injection Revenue (2018-2029)
8.2 China Rituximab Injection Market Size by Application
8.2.1 China Rituximab Injection Sales by Application (2018-2029)
8.2.2 China Rituximab Injection Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Rituximab Injection Market Size by Type
9.1.1 Asia Rituximab Injection Sales by Type (2018-2029)
9.1.2 Asia Rituximab Injection Revenue by Type (2018-2029)
9.2 Asia Rituximab Injection Market Size by Application
9.2.1 Asia Rituximab Injection Sales by Application (2018-2029)
9.2.2 Asia Rituximab Injection Revenue by Application (2018-2029)
9.3 Asia Rituximab Injection Sales by Region
9.3.1 Asia Rituximab Injection Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Rituximab Injection Revenue by Region (2018-2029)
9.3.3 Asia Rituximab Injection Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Rituximab Injection Market Size by Type
10.1.1 Middle East, Africa and Latin America Rituximab Injection Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Rituximab Injection Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Rituximab Injection Market Size by Application
10.2.1 Middle East, Africa and Latin America Rituximab Injection Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Rituximab Injection Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Rituximab Injection Sales by Country
10.3.1 Middle East, Africa and Latin America Rituximab Injection Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Rituximab Injection Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Rituximab Injection Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Rituximab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Pfizer Rituximab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Amgen
11.2.1 Amgen Company Information
11.2.2 Amgen Overview
11.2.3 Amgen Rituximab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Amgen Rituximab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Amgen Recent Developments
11.3 Roche
11.3.1 Roche Company Information
11.3.2 Roche Overview
11.3.3 Roche Rituximab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Roche Rituximab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Roche Recent Developments
11.4 Celltrion
11.4.1 Celltrion Company Information
11.4.2 Celltrion Overview
11.4.3 Celltrion Rituximab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Celltrion Rituximab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Celltrion Recent Developments
11.5 Innovent Biologics
11.5.1 Innovent Biologics Company Information
11.5.2 Innovent Biologics Overview
11.5.3 Innovent Biologics Rituximab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Innovent Biologics Rituximab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Innovent Biologics Recent Developments
11.6 Intas Pharmaceuticals
11.6.1 Intas Pharmaceuticals Company Information
11.6.2 Intas Pharmaceuticals Overview
11.6.3 Intas Pharmaceuticals Rituximab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Intas Pharmaceuticals Rituximab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Intas Pharmaceuticals Recent Developments
11.7 Shanghai Henlius Biotech
11.7.1 Shanghai Henlius Biotech Company Information
11.7.2 Shanghai Henlius Biotech Overview
11.7.3 Shanghai Henlius Biotech Rituximab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Shanghai Henlius Biotech Rituximab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Shanghai Henlius Biotech Recent Developments
11.8 Fosun-Pharmaceutical
11.8.1 Fosun-Pharmaceutical Company Information
11.8.2 Fosun-Pharmaceutical Overview
11.8.3 Fosun-Pharmaceutical Rituximab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Fosun-Pharmaceutical Rituximab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Fosun-Pharmaceutical Recent Developments
11.9 Lexicare Pharma
11.9.1 Lexicare Pharma Company Information
11.9.2 Lexicare Pharma Overview
11.9.3 Lexicare Pharma Rituximab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Lexicare Pharma Rituximab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Lexicare Pharma Recent Developments
11.10 Healthiza Lifescience
11.10.1 Healthiza Lifescience Company Information
11.10.2 Healthiza Lifescience Overview
11.10.3 Healthiza Lifescience Rituximab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Healthiza Lifescience Rituximab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Healthiza Lifescience Recent Developments
11.11 Kavya Pharma
11.11.1 Kavya Pharma Company Information
11.11.2 Kavya Pharma Overview
11.11.3 Kavya Pharma Rituximab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Kavya Pharma Rituximab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Kavya Pharma Recent Developments
11.12 Cadila Pharmaceuticals
11.12.1 Cadila Pharmaceuticals Company Information
11.12.2 Cadila Pharmaceuticals Overview
11.12.3 Cadila Pharmaceuticals Rituximab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Cadila Pharmaceuticals Rituximab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Cadila Pharmaceuticals Recent Developments
11.13 Dr Reddy’s Laboratories
11.13.1 Dr Reddy’s Laboratories Company Information
11.13.2 Dr Reddy’s Laboratories Overview
11.13.3 Dr Reddy’s Laboratories Rituximab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Dr Reddy’s Laboratories Rituximab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Dr Reddy’s Laboratories Recent Developments
11.14 Hetero Group
11.14.1 Hetero Group Company Information
11.14.2 Hetero Group Overview
11.14.3 Hetero Group Rituximab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Hetero Group Rituximab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Hetero Group Recent Developments
11.15 Probiomed
11.15.1 Probiomed Company Information
11.15.2 Probiomed Overview
11.15.3 Probiomed Rituximab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Probiomed Rituximab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Probiomed Recent Developments
11.16 TRPharma
11.16.1 TRPharma Company Information
11.16.2 TRPharma Overview
11.16.3 TRPharma Rituximab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 TRPharma Rituximab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 TRPharma Recent Developments
11.17 Zenotech Laboratories
11.17.1 Zenotech Laboratories Company Information
11.17.2 Zenotech Laboratories Overview
11.17.3 Zenotech Laboratories Rituximab Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 Zenotech Laboratories Rituximab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Zenotech Laboratories Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Rituximab Injection Industry Chain Analysis
12.2 Rituximab Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Rituximab Injection Production Mode & Process
12.4 Rituximab Injection Sales and Marketing
12.4.1 Rituximab Injection Sales Channels
12.4.2 Rituximab Injection Distributors
12.5 Rituximab Injection Customers
13 Market Dynamics
13.1 Rituximab Injection Industry Trends
13.2 Rituximab Injection Market Drivers
13.3 Rituximab Injection Market Challenges
13.4 Rituximab Injection Market Restraints
14 Key Findings in The Global Rituximab Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Rituximab Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 100 ml
Table 3. Major Manufacturers of 500 ml
Table 4. Global Rituximab Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Rituximab Injection Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Rituximab Injection Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Rituximab Injection Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Rituximab Injection Revenue Market Share by Region (2018-2024)
Table 9. Global Rituximab Injection Revenue Market Share by Region (2024-2029)
Table 10. Global Rituximab Injection Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Rituximab Injection Sales by Region (2018-2024) & (K Units)
Table 12. Global Rituximab Injection Sales by Region (2024-2029) & (K Units)
Table 13. Global Rituximab Injection Sales Market Share by Region (2018-2024)
Table 14. Global Rituximab Injection Sales Market Share by Region (2024-2029)
Table 15. Global Rituximab Injection Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Rituximab Injection Sales Share by Manufacturers (2018-2024)
Table 17. Global Rituximab Injection Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Rituximab Injection Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Rituximab Injection, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Rituximab Injection Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Rituximab Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Rituximab Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rituximab Injection as of 2022)
Table 23. Global Key Manufacturers of Rituximab Injection, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Rituximab Injection, Product Offered and Application
Table 25. Global Key Manufacturers of Rituximab Injection, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Rituximab Injection Sales by Type (2018-2024) & (K Units)
Table 28. Global Rituximab Injection Sales by Type (2024-2029) & (K Units)
Table 29. Global Rituximab Injection Sales Share by Type (2018-2024)
Table 30. Global Rituximab Injection Sales Share by Type (2024-2029)
Table 31. Global Rituximab Injection Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Rituximab Injection Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Rituximab Injection Revenue Share by Type (2018-2024)
Table 34. Global Rituximab Injection Revenue Share by Type (2024-2029)
Table 35. Rituximab Injection Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Rituximab Injection Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Rituximab Injection Sales by Application (2018-2024) & (K Units)
Table 38. Global Rituximab Injection Sales by Application (2024-2029) & (K Units)
Table 39. Global Rituximab Injection Sales Share by Application (2018-2024)
Table 40. Global Rituximab Injection Sales Share by Application (2024-2029)
Table 41. Global Rituximab Injection Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Rituximab Injection Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Rituximab Injection Revenue Share by Application (2018-2024)
Table 44. Global Rituximab Injection Revenue Share by Application (2024-2029)
Table 45. Rituximab Injection Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Rituximab Injection Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Rituximab Injection Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Rituximab Injection Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Rituximab Injection Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Rituximab Injection Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Rituximab Injection Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Rituximab Injection Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Rituximab Injection Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Rituximab Injection Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Rituximab Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Rituximab Injection Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Rituximab Injection Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Rituximab Injection Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Rituximab Injection Sales by Country (2024-2029) & (K Units)
Table 60. Europe Rituximab Injection Sales by Type (2018-2024) & (K Units)
Table 61. Europe Rituximab Injection Sales by Type (2024-2029) & (K Units)
Table 62. Europe Rituximab Injection Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Rituximab Injection Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Rituximab Injection Sales by Application (2018-2024) & (K Units)
Table 65. Europe Rituximab Injection Sales by Application (2024-2029) & (K Units)
Table 66. Europe Rituximab Injection Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Rituximab Injection Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Rituximab Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Rituximab Injection Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Rituximab Injection Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Rituximab Injection Sales by Country (2018-2024) & (K Units)
Table 72. Europe Rituximab Injection Sales by Country (2024-2029) & (K Units)
Table 73. China Rituximab Injection Sales by Type (2018-2024) & (K Units)
Table 74. China Rituximab Injection Sales by Type (2024-2029) & (K Units)
Table 75. China Rituximab Injection Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Rituximab Injection Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Rituximab Injection Sales by Application (2018-2024) & (K Units)
Table 78. China Rituximab Injection Sales by Application (2024-2029) & (K Units)
Table 79. China Rituximab Injection Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Rituximab Injection Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Rituximab Injection Sales by Type (2018-2024) & (K Units)
Table 82. Asia Rituximab Injection Sales by Type (2024-2029) & (K Units)
Table 83. Asia Rituximab Injection Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Rituximab Injection Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Rituximab Injection Sales by Application (2018-2024) & (K Units)
Table 86. Asia Rituximab Injection Sales by Application (2024-2029) & (K Units)
Table 87. Asia Rituximab Injection Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Rituximab Injection Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Rituximab Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Rituximab Injection Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Rituximab Injection Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Rituximab Injection Sales by Region (2018-2024) & (K Units)
Table 93. Asia Rituximab Injection Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Rituximab Injection Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Rituximab Injection Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Rituximab Injection Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Rituximab Injection Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Rituximab Injection Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Rituximab Injection Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Rituximab Injection Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Rituximab Injection Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Rituximab Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Rituximab Injection Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Rituximab Injection Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Rituximab Injection Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Rituximab Injection Sales by Country (2024-2029) & (K Units)
Table 107. Pfizer Company Information
Table 108. Pfizer Description and Major Businesses
Table 109. Pfizer Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Pfizer Rituximab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Pfizer Recent Developments
Table 112. Amgen Company Information
Table 113. Amgen Description and Major Businesses
Table 114. Amgen Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Amgen Rituximab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Amgen Recent Developments
Table 117. Roche Company Information
Table 118. Roche Description and Major Businesses
Table 119. Roche Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Roche Rituximab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Roche Recent Developments
Table 122. Celltrion Company Information
Table 123. Celltrion Description and Major Businesses
Table 124. Celltrion Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Celltrion Rituximab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Celltrion Recent Developments
Table 127. Innovent Biologics Company Information
Table 128. Innovent Biologics Description and Major Businesses
Table 129. Innovent Biologics Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Innovent Biologics Rituximab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Innovent Biologics Recent Developments
Table 132. Intas Pharmaceuticals Company Information
Table 133. Intas Pharmaceuticals Description and Major Businesses
Table 134. Intas Pharmaceuticals Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Intas Pharmaceuticals Rituximab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Intas Pharmaceuticals Recent Developments
Table 137. Shanghai Henlius Biotech Company Information
Table 138. Shanghai Henlius Biotech Description and Major Businesses
Table 139. Shanghai Henlius Biotech Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Shanghai Henlius Biotech Rituximab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Shanghai Henlius Biotech Recent Developments
Table 142. Fosun-Pharmaceutical Company Information
Table 143. Fosun-Pharmaceutical Description and Major Businesses
Table 144. Fosun-Pharmaceutical Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Fosun-Pharmaceutical Rituximab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Fosun-Pharmaceutical Recent Developments
Table 147. Lexicare Pharma Company Information
Table 148. Lexicare Pharma Description and Major Businesses
Table 149. Lexicare Pharma Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Lexicare Pharma Rituximab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Lexicare Pharma Recent Developments
Table 152. Healthiza Lifescience Company Information
Table 153. Healthiza Lifescience Description and Major Businesses
Table 154. Healthiza Lifescience Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Healthiza Lifescience Rituximab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Healthiza Lifescience Recent Developments
Table 157. Kavya Pharma Company Information
Table 158. Kavya Pharma Description and Major Businesses
Table 159. Kavya Pharma Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Kavya Pharma Rituximab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Kavya Pharma Recent Developments
Table 162. Cadila Pharmaceuticals Company Information
Table 163. Cadila Pharmaceuticals Description and Major Businesses
Table 164. Cadila Pharmaceuticals Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Cadila Pharmaceuticals Rituximab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Cadila Pharmaceuticals Recent Developments
Table 167. Dr Reddy’s Laboratories Company Information
Table 168. Dr Reddy’s Laboratories Description and Major Businesses
Table 169. Dr Reddy’s Laboratories Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Dr Reddy’s Laboratories Rituximab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Dr Reddy’s Laboratories Recent Developments
Table 172. Hetero Group Company Information
Table 173. Hetero Group Description and Major Businesses
Table 174. Hetero Group Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. Hetero Group Rituximab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Hetero Group Recent Developments
Table 177. Probiomed Company Information
Table 178. Probiomed Description and Major Businesses
Table 179. Probiomed Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 180. Probiomed Rituximab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Probiomed Recent Developments
Table 182. TRPharma Company Information
Table 183. TRPharma Description and Major Businesses
Table 184. TRPharma Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 185. TRPharma Rituximab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. TRPharma Recent Developments
Table 187. Zenotech Laboratories Company Information
Table 188. Zenotech Laboratories Description and Major Businesses
Table 189. Zenotech Laboratories Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 190. Zenotech Laboratories Rituximab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 191. Zenotech Laboratories Recent Developments
Table 192. Key Raw Materials Lists
Table 193. Raw Materials Key Suppliers Lists
Table 194. Rituximab Injection Distributors List
Table 195. Rituximab Injection Customers List
Table 196. Rituximab Injection Market Trends
Table 197. Rituximab Injection Market Drivers
Table 198. Rituximab Injection Market Challenges
Table 199. Rituximab Injection Market Restraints
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. Rituximab Injection Product Picture
Figure 2. Global Rituximab Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Rituximab Injection Market Share by Type in 2022 & 2029
Figure 4. 100 ml Product Picture
Figure 5. 500 ml Product Picture
Figure 6. Global Rituximab Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Rituximab Injection Market Share by Application in 2022 & 2029
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Others
Figure 11. Rituximab Injection Report Years Considered
Figure 12. Global Rituximab Injection Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Rituximab Injection Revenue 2018-2029 (US$ Million)
Figure 14. Global Rituximab Injection Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Rituximab Injection Revenue Market Share by Region (2018-2029)
Figure 16. Global Rituximab Injection Sales 2018-2029 ((K Units)
Figure 17. Global Rituximab Injection Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Rituximab Injection Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Rituximab Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Rituximab Injection Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Rituximab Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Rituximab Injection Sales YoY (2018-2029) & (K Units)
Figure 23. China Rituximab Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Rituximab Injection Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Rituximab Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Rituximab Injection Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Rituximab Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Rituximab Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Rituximab Injection in the World: Market Share by Rituximab Injection Revenue in 2022
Figure 30. Global Rituximab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Rituximab Injection Sales Market Share by Type (2018-2029)
Figure 32. Global Rituximab Injection Revenue Market Share by Type (2018-2029)
Figure 33. Global Rituximab Injection Sales Market Share by Application (2018-2029)
Figure 34. Global Rituximab Injection Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Rituximab Injection Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Rituximab Injection Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Rituximab Injection Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Rituximab Injection Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Rituximab Injection Revenue Share by Country (2018-2029)
Figure 40. US & Canada Rituximab Injection Sales Share by Country (2018-2029)
Figure 41. U.S. Rituximab Injection Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Rituximab Injection Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Rituximab Injection Sales Market Share by Type (2018-2029)
Figure 44. Europe Rituximab Injection Revenue Market Share by Type (2018-2029)
Figure 45. Europe Rituximab Injection Sales Market Share by Application (2018-2029)
Figure 46. Europe Rituximab Injection Revenue Market Share by Application (2018-2029)
Figure 47. Europe Rituximab Injection Revenue Share by Country (2018-2029)
Figure 48. Europe Rituximab Injection Sales Share by Country (2018-2029)
Figure 49. Germany Rituximab Injection Revenue (2018-2029) & (US$ Million)
Figure 50. France Rituximab Injection Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Rituximab Injection Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Rituximab Injection Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Rituximab Injection Revenue (2018-2029) & (US$ Million)
Figure 54. China Rituximab Injection Sales Market Share by Type (2018-2029)
Figure 55. China Rituximab Injection Revenue Market Share by Type (2018-2029)
Figure 56. China Rituximab Injection Sales Market Share by Application (2018-2029)
Figure 57. China Rituximab Injection Revenue Market Share by Application (2018-2029)
Figure 58. Asia Rituximab Injection Sales Market Share by Type (2018-2029)
Figure 59. Asia Rituximab Injection Revenue Market Share by Type (2018-2029)
Figure 60. Asia Rituximab Injection Sales Market Share by Application (2018-2029)
Figure 61. Asia Rituximab Injection Revenue Market Share by Application (2018-2029)
Figure 62. Asia Rituximab Injection Revenue Share by Region (2018-2029)
Figure 63. Asia Rituximab Injection Sales Share by Region (2018-2029)
Figure 64. Japan Rituximab Injection Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Rituximab Injection Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Rituximab Injection Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Rituximab Injection Revenue (2018-2029) & (US$ Million)
Figure 68. India Rituximab Injection Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Rituximab Injection Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Rituximab Injection Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Rituximab Injection Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Rituximab Injection Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Rituximab Injection Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Rituximab Injection Sales Share by Country (2018-2029)
Figure 75. Brazil Rituximab Injection Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Rituximab Injection Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Rituximab Injection Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Rituximab Injection Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Rituximab Injection Revenue (2018-2029) & (US$ Million)
Figure 80. Rituximab Injection Value Chain
Figure 81. Rituximab Injection Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries